Testing version — LOERadar is in active testing. Features and data may change.
OTEZLA (APREMILAST) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
OTEZLA
NDANot in Orange Book
APREMILAST | N206088 | CELGENE CORP
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (3)
Sort:
#001 — 10MG
▴
TABLET;ORAL | Approved: Sep. 23, 2014
No patent or exclusivity listings for this strength.